Intrexon

The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down
Yahoo/Benzinga
Sun, 11/17/19 - 08:47 pm
AHA
The Medicines Company
Intrexon
Alnylam
Pieris
Roche
4 US pharma execs make Forbes 400 list
BioPharma Dive
Wed, 10/19/16 - 06:47 pm
Patrick Soon-Shiong
NantWorks
Phillip Frost
OPKO Health
Randal Kirk
Intrexon
Robert Duggan
Pharmacyclics
7 Companies in the Fight to Defeat the Zika Virus
24/7 Wall St
Thu, 05/26/16 - 09:56 am
Zika virus
R&D
Gilead Sciences
Inovio
Intrexon
NewLink Genetics
Quest Diagnostics
Sanofi
The Race to Cure the Zika Virus is On, and This Company May Have the Best Solution
Motley Fool
Sun, 04/17/16 - 11:20 am
Zika virus
Invovio
GSK
NewLink Genetics
Sanofi
Merck
Cerus
Intrexon
Is ZIOPHARM Poised For Acquisition?
Seeking Alpha
Mon, 03/28/16 - 06:57 pm
Ziopharm
M&A
Intrexon
3 Biotech Stocks That Could Be Buyout Targetst
Motley Fool
Fri, 08/21/15 - 09:46 am
Intrexon
Ziopharm
Bluebird Bio
Biomarin
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Yahoo
Mon, 03/30/15 - 11:11 am
Intrexon
Merck Serono
CAR-T
chimeric antigen receptor T-cell immunotherapies
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed
Motley Fool
Sun, 03/1/15 - 11:32 am
Intrexon
CAR-T
Zogenix
ActoGeniX
Booming biotechs bank $2.7B in follow-on cash
Fierce Biotech
Fri, 01/23/15 - 03:38 pm
biotech
Prosensa
Biomarin
Zafgen
Alnylam
Auspex
Puma Biotechnology
Arena Pharmaceuticals
Radius Health
Intrexon
The 10 Most Heavily Shorted Bio-Pharma Stocks
TheStreet.com
Mon, 02/24/14 - 11:15 am
Spectrum Pharmaceuticals
Dendreon
Achillion
Ziopharm
Intrexon
Arena Pharmaceuticals
Idenix
Synta Pharmaceuticals
Sarepta Therapeutics
Myriad Genetics
The Best- And Worst-Performing Biotech Stocks,Jan. 3 to Jan. 10
Forbes
Sat, 01/11/14 - 10:13 am
Neurocrine
Intercept Pharma
Epizyme
Sangamo BioSciences
OncoMed
Zogenix
Macrogenics
Intrexon
Pharmacyclics
Galena Biopharma
Intrexon to Acquire Medistem to Generate Multipotent Cells
Yahoo
Fri, 12/20/13 - 11:45 am
Intrexon
MediStem
M&A
Ziopharm: Finally A Winner In The War On Cancer?
Seeking Alpha
Mon, 12/16/13 - 08:06 am
Ziopharm
cancer
AbbVie
Amgen
Celgene
Celldex Therapeutics
Gilead Sciences
Immunogen
JNJ
ImmunoCellular Therapeutics
Pharmacyclics
Intrexon
Seattle Genetics
This Biotech Trifecta Could Revolutionize Cancer
Motley Fool
Sun, 10/27/13 - 12:53 pm
Intrexon
Ziopharm
Amgen
Osiris Therapeutics
Fresh burst of biotech IPO pitches launches a busy Q4 season
Fierce Biotech
Tue, 10/22/13 - 11:51 am
IPOs
Foundation Medicine
Ophthotech
Intrexon
Onconova
Agios
OncoMed
3 Red Flags for This Biotech IPO
Motley Fool
Mon, 10/21/13 - 04:13 pm
Intrexon
IPOs
Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - Angel Broking
Equity Bulls
Sat, 10/5/13 - 10:26 am
Sun Pharma
Intrexon
wet age-related macular degeneration
age-related macular degeneration
macular
edema
uveitis
diabetic retinopathy
A Time to Test Biotechs' Strength
The Street
Sun, 08/25/13 - 11:31 am
Bluebird Bio
Epizyme
Intrexon
NanoString Technologies
LipoScience
Aratana
Heat Biologics
ONYX Pharmaceuticals
Amgen
Is This Biotech Stock Worth Buying After a Massive Post-IPO Surge?
Motley Fool
Tue, 08/13/13 - 11:06 am
IPOs
Intrexon
Eli Lilly
synthetic DNA
Biotech company Intrexon shares surge 38 pct in debut
Reuters
Thu, 08/8/13 - 02:27 pm
Intrexon
IPOs

Pages